Baxter gains FDA clearance of infusion pump

DEERFIELD - Baxter International Inc. said the Food and Drug Administration has granted medical device clearance for its new Novum IQ syringe infusion pump and related software.

Syringe infusion pumps are typically used to precisely deliver small amounts of fluid at low rates, often in pediatric, neonatal or anesthesia care settings.

The Novum system has the capability to fully integrate with hospital electronic medical records and meets rigorous FDA guidance for infusion devices, including cybersecurity, Baxter said. The pump and software offer enhanced safety features, advanced connectivity, configurable anesthesia care settings and a robust portfolio of features designed to help deliver optimum accuracy.

"Together, the Novum IQ syringe infusion pump, Dose IQSafety software and IQ Enterprise Connectivity Suite advance the interoperability and data insights needed to help prevent harm and personalize therapy for patients, including neonates and other fragile patients," said Heather Knight, president of Baxter's medication delivery, acute therapies, clinical nutrition business in Latin America and Canada.